 |
|
Refine By Categories
Regulatory Processes
Diseases
Protein Regulatory Pathways
|
 |
|
 |
|
|
Results
|
|
|
 |
| Showing 1 - 6 out of 6 |
Result pages:
1 |
|
Apoptosis and survival_Regulation of Apoptosis by Mitochondrial Proteins [score: 1 (0%)]
Regulation of Apoptosis by Mitochondrial
Proteins
Apoptosis is an evolutionarily conserved type of programmed cell death essential for
development, homeostasis, and self-defense against infection. It can be triggered by a
number of factors including UV- or gamma-irradiation, chemotherapeutic ...
Apoptosis and survival_Caspase cascade [score: 1 (0%)]
Caspase cascade
Caspases are the central components of the apoptotic response. The apoptotic caspases
are generally divided into two classes: the initiator caspases, which include
caspase-2, -8,
-9 and -10 and the effector
caspases, which include ...
Transcription_P53 signaling pathway [score: 1 (0%)]
p53 signaling
pathway
The Tumor protein p53 (p53) plays a critical role in
safeguarding the integrity of the genome. Upon activation,
p53 binds to the enhancer/promoter elements of downstream
target genes and regulates their transcription, through which it initiates ...
DNA damage_ATM/ATR regulation of G1/S checkpoint [score: 1 (0%)]
ATM/ATR regulation of G1/S and S/G2
checkpoints
DNA damage checkpoints are biochemical pathways that delay or arrest the cell cycle
progression in response to the DNA damage. All eukaryotic cells have four phases within
the cell cycle, G1, S, G2, and M, and one outside, ...
DNA damage_Role of Brca1 and Brca2 in DNA repair [score: 1 (0%)]
Role of Brca1 and Brca2 in DNA Repair
DNA damage-dependent activation of the breast and ovarian cancer susceptibility
protein 1 (Brca1) occurs via activation of ataxia
telangiectasia mutated serine-protein kinase
(ATM) [1] or ataxia
telangiectasia ...
Apoptosis and survival_BAD phosphorylation [score: 1 (0%)]
BAD phosphorylation
BAD is a member of the BCL-2 family. BCL-2 family members are
regulators of the programmed cell death pathways.
BAD induces apoptosis by inhibiting antiapoptotic ...
|
|
|
|
|